[1] Li H,Liu XW,Geng ZJ,et al. Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma[J].Dentomaxil Radiol,2015,44:20140126.
[2] Stadnik TW,Chaskis C,Michotte A,et al. Diffusion-weighted MR imaging of intracerebral masses:comparison with conventional MR imaging and histologic findings[J].Am. J Neuroradiol,2001,22(5):969-976.
[3] Zhang Y,Liu X,Zhang Y,et al. Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma:a retrospective study of 541 cases[J].Sci Rep,2015,5:12242.DOI:10.1038/srep12242.
[4] Valles FE,Perez-Valles CL,Regalado S,et al. Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma[J].Am J Neuroradiol,2013,34(1):35-40.DOI:10.3174/ajnr. A3165.30.
[5] King AD,Chow KK,Yu KH,et al. Head and neck squamous cell carcinoma:diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response[J].Radiology,2013,266(2):531-538.DOI:10.1148/radiol.12120167.
[6] Zhao M,Liu Z,Sha Y,et al. Readout-segmented echo-planar imaging in the evaluation of sinonasal lesions:A comprehensive comparison of image quality in single-shot echo-planar imaging[J].Magn Reson Imag,2016,34(2):166-172.DOI:10.1016/j.mri.2015.10.010.
[7] Friedli I,Crowe LA,Viallon M,et al. Improvement of renal diffusion-weighted magnetic resonance imaging with readout-segmented echo-planar imaging at 3T[J].Magn Reson Imag,2015,33(6):701-708.DOI:10.1016/j.mri.2015.02.023.
[8] Hori M,Fukunaga I,Masutani Y,et al. Visualizing non-Gaussian diffusion:clinical application of q-space imaging and diffusional kurtosis imaging of the brain and spine[J]. Magn Reson Med Sci,2012,11(4):221-233.
[9] Jiang R,Jiang J,Zhao L,et al. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation[J]. Oncotarget,2015,6(39):42380-42393.DOI:10.18632/oncotarget.5675.
[10] Kamagata K,Tomiyama H,Hatano T,et al. A preliminary diffusional kurtosis imaging study of Parkinson disease:comparison with conventional diffusion tensor imaging[J]. Neuroradiology,2014,56(3):251-258.DOI:10.1007/s00234-014-1327-1.
[11] Yu XP,Hou J,Li FP,et al. Intravoxel incoherent motion diffusion weighted magnetic resonance imaging for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site[J].J Comput Assist Tomogr,2016,40(3):413-418.DOI:10.1097/RCT.0000000000000391.
[12] Chen Y,Ren W,Zheng D,et al. Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients[J].J Magn Reson Imag,2015,42(5):1354-1361.DOI:10.1002/jmri.24910.
[13] Fujima N,Yoshida D,Sakashita T,et al. Prediction of the treatment outcome using intravoxel incoherent motion and diffusional kurtosis imaging in nasal or sinonasal squamous cell carcinoma patients[J].Eur Radiol,2017,27(3):956-965.DOI:10.1007/s00330-016-4440-1.
[14] Zong J,Lin S,Lin J,et al. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma:Validation of the 7th edition AJCC staging system[J]. Oral Oncol,2015,51(3):254-259.DOI:10.1016/j.oraloncology.2014.10.012.
[15] Lombardi M,Cascone T,Guenzi E,et al. Predictive value of prr-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma[J].Radiol Med,2017,122(5):345-352.DOI:10.1007/s11547-017-0733-y.
[16] Chen Y,Liu X,Zheng D,et al. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma[J].Magn Reson Imag,014,32(6):630-637.DOI:10.1016/j.mri.2014.02.009.
[17] Hong J,Yao Y,Zhang Y,et al. Value of magnetic resonance diffusion-weighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma[J].Otolaryngol Head Neck Surg,2013,149(5):707-713. DOI:10.1177/0194599813496537.
[18] Huang WY,Wen JB,Wu G,et al. Diffusion-weighted imaging for predicting and monitoring primary central nervous system lymphoma treatment response[J].Am J Neuroradiol.2016,37(11):2010-2018.DOI:https://doi.org/10.3174/ajnr. A4867.
[19] Davnall F,Yip CS,Ljungqvist G,et al. Assessment of tumor heterogeneity:an emerging imaging tool for clinical practice?[J].Insig Imag,2012,3(6):573-589.DOI:10.1007/s13244-012-0196-6.
[20] Mardor Y,Roth Y,Ochershvilli A,et al. Pretreatment prediction of brain tumors’ response to radiation therapy using high b-value diffusion-weighted MRI[J].Neoplasia.2004,6(2):136-142.DOI:10.1593/neo.03349.
[21] Yu J,Xu Q,Song JC,et al. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J].Eur Radiol.2017,27(5):1848-1857.DOI:10.1007/s00330-016-4529-6. Epub 2016 Sep 8.
[22] Yuan J,Yeung DK,Mok GS,et al. Non-Gaussian analysis of diffusion weighted imaging in head and neck at 3T:a pilot study in patients with nasopharyngeal carcinoma[J].PLoS One,2014,9(1):e87024.DOI:10.1371/journal.pone.0087024.eCollection 2014.
[23] Jambor I,Merisaari H,Taimen P,et al. Evaluation of different mathematical models for diffusion-weighted imaging of normal prostate and prostate Cancer using high b-values:a repeatability study[J].Magn Reson Med,2015,73(5):1988-1998.DOI:10.1002/mrm.25323.
[24] Harrison L,Blackwell K.Hypoxia and anemia:factors in decreased sensitivity to radiation therapy and chemotherapy?[J].Oncologist,2004,9(suppl 5):31-40.DOI:10.1634/theoncologist.9-90005-31.
[25] Zhu L,Pan Z,Ma Q,et al. Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors:preliminary findings[J].Radiology,2017,284(1):66-76.DOI:10.1148/radiol.2016160094.
[26] Raja R,Sinha N,Saini J,et al. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas[J].Neuroradiology,2016,58(12):1217-1231.DOI:10.1007/s00234-016-1758-y.
[27] Marusyk A,Almendro V,Polyak K.Intra-tumour heterogeneity:a looking glass for cancer?[J].Nat Rev Cancer,2012,12(5):323-334.DOI:10.1038/nrc3261. |